SENS-401
Cochlear Preservation after Cochlear Implantation
Key Facts
About Sensorion
Sensorion's mission is to find solutions for hearing disorders by building a portfolio of innovative therapies through its three strategic pillars: Restore, Treat, and Prevent. The company leverages a unique internal R&D platform to advance its pipeline, with key assets like OTOF-GT in Phase 1/2 and SENS-401 in Phase 2. Its clear strategy focuses on addressing a large, underserved market in inner ear diseases through both proprietary development and strategic partnerships.
View full company profileAbout Sensorion
Sensorion's mission is to find solutions for hearing disorders by building a portfolio of innovative therapies through its three strategic pillars: Restore, Treat, and Prevent. The company leverages a unique internal R&D platform to advance its pipeline, with key assets like OTOF-GT in Phase 1/2 and SENS-401 in Phase 2. Its clear strategy focuses on addressing a large, underserved market in inner ear diseases through both proprietary development and strategic partnerships.
View full company profileAbout Sensorion
Sensorion's mission is to find solutions for hearing disorders by building a portfolio of innovative therapies through its three strategic pillars: Restore, Treat, and Prevent. The company leverages a unique internal R&D platform to advance its pipeline, with key assets like OTOF-GT in Phase 1/2 and SENS-401 in Phase 2. Its clear strategy focuses on addressing a large, underserved market in inner ear diseases through both proprietary development and strategic partnerships.
View full company profile